Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients

SHANG-YI HUANGLin, Hsiu-HsiaHsiu-HsiaLinMING YAOJIH-LUH TANGSHANG-JU WUWEN-CHIEN CHOUSZU-CHUN HSUBOR-SHENG KOHWEI-FANG TIEN2022-04-262022-04-262022-030929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/608084Decorin is a small leucine-rich proteoglycan rich in extracellular matrix with potential antitumor activity. However, the role of decorin in hematological malignancies remains unclear, especially in the case of multiple myeloma (MM), a bone marrow (BM) stroma-dependent plasma cell neoplasm.enDecorin; Extracellular matrix; Hepatocyte growth factor; Mesenchymal stem cell; MyelomaBone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patientsjournal article10.1016/j.jfma.2021.06.015342465092-s2.0-85109451075